Mesoblast Target Price

Mesoblast (MESO) currently reports a target price of $39. Use the charts on this page to explore Mesoblast's target price history and peer comparisons.

Analysts' average 12-month price target for Mesoblast is $39, about 125.6% upside from the current share price of $17.29. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $39, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mesoblast, and consider following MESO for alerts when major investors trade the stock.

Mesoblast is classified in the Healthcare sector. On target price, it currently shows $39. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MESO with unrelated industries.